Enhanced Vascularization in Hybrid PCL/Gelatin Fibrous Scaffolds with Sustained Release of VEGF

Figure 6

Representative hematoxylin and eosin (H&E) staining of explanted scaffolds after subcutaneous implantation for 2 (a, c, e, and g) and 4 (b, d, f, and h) weeks (): PCL (a and b); VEGF loaded PCL (c and d); VEGF loaded Hep-PCL/Gel-1 (e and f); VEGF loaded Hep-PCL/Gel-2 (g and h) (scale bars = 1 mm), and the corresponding quantitative analysis of cell migration (i). ; .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)